Replies to post #16006 on Mymetics Corp (MYMX)

[Work Harder]

Link for that

https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=3&ved=2ahUKEwj58e_ZvLjnAhXDQc0KHZ4KABwQFjACegQIBhAB&url=https%3A%2F%2Fwww.escmid.org%2Fescmid_publications%2Fescmid_elibrary%2Fmaterial%2F%3Fmid%3D63809&usg=AOvVaw3QZAkgf5Xvq0YZFW1nw7HZ

Conclusions: R21/MM has shown encouraging durable protection against malaria in healthy UK
adults. Unsurpassed efficacy for a two-dose regimen offers additional promise for incorporation into
EPI, potentially with a 6-month booster. Progression to field testing is now planned.